Form 4: Illumina Director Gary Guthart Receives Restricted Stock Unit Grant and Spin-Out Adjustment

Illumina, Inc. Director Gary S. Guthart was granted 3,780 restricted stock units (RSUs) on May 21, 2025, as part of his compensation, with an adjustment of 53 units related to the Grail spin-out.

Summary

• Illumina, Inc. Director Gary S. Guthart acquired 3,780 shares of common stock in the form of restricted stock units (RSUs) on May 21, 2025.
• The RSUs were granted at a price of $0, indicating they are part of compensation.
• Following this transaction, Mr. Guthart beneficially owns 16,430 shares of common stock directly.
• The granted RSUs will vest 100% on the earlier of the one-year anniversary of the grant date or the day immediately preceding the company's annual meeting for the year following the grant, contingent on continued service as a director.
• Additionally, Mr. Guthart's unvested RSUs were increased by 53 units due to an adjustment related to Illumina's spin-out of Grail, Inc., which was completed on June 24, 2024.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a director, which is a positive for aligning interests but not a significant market-moving event. The adjustment for the spin-out is also a neutral, expected corporate action.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The adjustment to unvested RSUs due to the Grail spin-out ensures that the director's equity awards are appropriately maintained following a significant corporate event.

Negatives

• No negative information is typically disclosed in a Form 4 filing, which primarily reports changes in beneficial ownership.

Risks

• This document, a Form 4, does not typically disclose company-specific risks. It is a regulatory filing for insider trading transparency.

Future Outlook

The vesting schedule for the granted restricted stock units indicates a future commitment for Director Gary S. Guthart to continue serving on the board for at least one year to fully realize the value of the award.

Industry Context

The grant of restricted stock units is a common form of equity compensation for directors in the biotechnology and life sciences industry, aiming to align their long-term interests with shareholder value creation. The adjustment related to the Grail spin-out reflects standard practices for maintaining equity award integrity during significant corporate restructuring events.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) as part of director compensation is a widely adopted practice across publicly traded companies, including those in the biotech and genomics sectors like Illumina.
• The vesting schedule, typically over one year or tied to the next annual meeting, is standard for director equity awards, ensuring continued board service.
• Adjustments to outstanding equity awards following spin-offs or other corporate transactions, such as the one seen with the Grail spin-out, are common and necessary to preserve the economic value and intent of the original grants, aligning with best practices in corporate governance and compensation.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's financial interests with shareholder value, as the value of the compensation is directly tied to the company's stock performance.
• Director (Gary S. Guthart): Receives equity compensation, incentivizing continued service and performance.

Next Steps

• The granted restricted stock units are expected to vest on the earlier of May 21, 2026 (one-year anniversary) or the date immediately preceding Illumina's annual meeting for 2026, provided Mr. Guthart continues to serve as a director.

Key Dates

Keywords

Illumina, ILMN, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Corporate Governance, Gary Guthart, Grail Spin-out